INNOVATION PHARMACEUTICALS INC. Proceeds from Fees Received
INNOVATION PHARMACEUTICALS INC. reported Proceeds from Fees Received of $1.00 million for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromFeesReceived · last filed 2021-09-27
- INNOVATION PHARMACEUTICALS INC. proceeds from fees received for fiscal 2021 was $1.00M.
| Period end | Proceeds from Fees Received 12 month |
|---|---|
| 2021-06-30 | $1.00M 10-K · filed 2021-09-27 |